Genetic mutations in many forms of ALS lead to early problems with the transport and function of mitochondria, a study found.

Learn how a new genetic therapy could transform treatment for rare ALS—keep reading for remarkable patient outcomes.

The global food allergy market is experiencing remarkable growth, projected to reach a valuation of USD 66.15 Billion by the end of 2033, expanding at a CAGR of 5.2% from its estimated value of USD 39 ...

Stephen Hawking warned years ago that the development of advanced artificial intelligence could pose a serious threat to ...

The ALS Network is supporting research using electronic health records to identify existing drugs for repurposing to slow ALS ...

Typically, the goal of ALS treatments is to slow the disease or halt progression. But new data from the antisense oligonucleotide (ASO) jacifusen for FUS-ALS show that two patients went beyond the ...

Potts: NPH is a form of hydrocephalus, a build-up of CSF in the brain. It's typically seen in older patients, usually over ...

Melissa Diaz-Viera and her husband Robert Lang were overjoyed to have a baby after years of trying to get pregnant and also ...

Experimental drug Ulefnersen offers hope for rare, early-onset Amyotrophic lateral sclerosis (ALS) in clinical trials.

The CRISPR gene editing tool has been revolionary for the research lab, and it has also been used to transform the lives ... | Genetics And Genomics ...

163.com Conclusions These findings demonstrated that the genetic architecture of ALS in Asian populations is distinct from that in European populations, which need to be given appropriate ...